<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pak J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Pak J Med Sci</journal-id><journal-title-group><journal-title>Pakistan Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1682-024X</issn><issn pub-type="epub">1681-715X</issn><publisher><publisher-name>Professional Medical Publications</publisher-name><publisher-loc>Pakistan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28811808</article-id><article-id pub-id-type="pmc">5510140</article-id><article-id pub-id-type="publisher-id">PJMS-33-752</article-id><article-id pub-id-type="doi">10.12669/pjms.333.12026</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Prevention of anesthesia-induced injection pain of propofol in pediatric anesthesia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Dabin</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Lu</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Zheng</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Dabin Cheng, Department of Anesthesiology, Children&#x02019;s Hospital of Nanjing Medical University, No. 72 Guangzhou Road, Nanjing 210008, Jiangsu Province, China</aff><aff id="aff2"><label>2</label>Lu Liu, Department of Anesthesiology, Children&#x02019;s Hospital of Nanjing Medical University, No. 72 Guangzhou Road, Nanjing 210008, Jiangsu Province, China</aff><aff id="aff3"><label>3</label>Zheng Hu, Department of Anesthesiology, Children&#x02019;s Hospital of Nanjing Medical University, No. 72 Guangzhou Road, Nanjing 210008, Jiangsu Province, China</aff><author-notes><corresp id="cor1">
Correspondence: Zheng Hu, Department of Anesthesiology, Children&#x02019;s Hospital of Nanjing Medical University, No. 72 Guangzhou Road, Nanjing 210008, Jiangsu Province, China. E-mail: <email xlink:href="huzhengnch@yeah.net">huzhengnch@yeah.net</email></corresp><fn><p><bold><italic>Note:</italic></bold> First two authors contributed to this work equally.</p></fn></author-notes><pub-date pub-type="ppub"><season>May-Jun</season><year>2017</year></pub-date><volume>33</volume><issue>3</issue><fpage>752</fpage><lpage>756</lpage><history><date date-type="received"><day>01</day><month>12</month><year>2017</year></date><date date-type="rev-recd"><day>24</day><month>4</month><year>2017</year></date><date date-type="rev-recd"><day>15</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>17</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Pakistan Journal of Medical Sciences</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>Propofol is a new anesthetic agent in clinical practice, but randomized double-blinded prospective studies on its role in pediatric anesthesia remain limited. We aimed to compare the preventive effects of pre-injected lidocaine or ketamine and its pre-mixture on the anesthesia-induced injection pain of propofol using a randomized double-blinded prospective method, and to compare the outcomes with those of medium-/long-chain propofol (M/LCT).</p></sec><sec id="st2"><title>Methods:</title><p>A total of 360 pediatric patients (aged 5-12 years old) who received elective surgery were randomly divided into six groups (n= 60) as follows. S group: control group; L group: lidocaine group; L + P group: lidocaine + propofol group; K group: ketamine group; K + P group: ketamine + propofol group; M group: M/LCT group. After the drug fluid completely entered the cubital vein, the venous access was closed. During propofol injection, the injection pain was scored using the VRS 4-point scale. Meanwhile, the heart rates before and during injection were recorded, the adverse reactions during and after injection were observed, and the incidence rate and degree of pain were evaluated.</p></sec><sec id="st3"><title>Results:</title><p>The VRS 4-point scale showed that the incidence rates of injection pain of S group, L group, L + P group, K group, K + P group and M group were 78.3%, 66.67%, 51.66%, 43.33%, 48.33% and 45% respectively. The incidence rates of injection pain of all experimental groups were significantly lower than that of S group (P&#x0003c;0.01). The incidence rates of injection pain of L + P group, K group, K + P group and M group were significantly lower than that of L group (P&#x0003c;0.05). The differences among the other groups were not statistically significant.</p></sec><sec id="st4"><title>Conclusions:</title><p>Intravenous pre-injection of lidocaine, ketamine or those mixed with propofol can all significantly reduce the incidence rate of injection pain of propofol.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd>Injection pain</kwd><kwd>Lidocaine</kwd><kwd>Ketamine</kwd><kwd>Propofol</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Propofol is a novel ultra-short-acting intravenous anesthetic agent with rapid effects,<xref rid="ref1" ref-type="bibr">1</xref> the main adverse reaction of which is injection pain. Obvious pain can be caused by peripheral intravenous injection.<xref rid="ref2" ref-type="bibr">2</xref> Propofol injection pain ranks 7th among the 33 major problems of clinical concern, with the incidence rates of 28%-90%.<xref rid="ref3" ref-type="bibr">3</xref></p><p>Among pediatric patients, the injection pain of propofol is an intractable problem. To solve the problem, anesthesiologists have used a number of methods, such as local anesthesia and cooling of drug fluid. In most cases, propofol injection is mixed with lidocaine.<xref rid="ref4" ref-type="bibr">4</xref> A meta-analysis showed that intravenous administration of 0.5 mg/kg lidocaine after tying a rubber tourniquet on the forearm 30-120 s before the injection of propofol relieved the pain of about 60% of patients.<xref rid="ref5" ref-type="bibr">5</xref> However, even using a variety of methods, propofol injection pain still cannot be completely prevented, with the incidence rates as high as 32%-48%.<xref rid="ref6" ref-type="bibr">6</xref></p><p>Currently, the commercially available formulation of dosage form is prepared by dissolving 1% propofol in 10% soybean oil emulsion. The emulsion contains complex ingredients, so the adaptability to intravenous infusion depends on many factors. The instability of emulsion itself may be one of the causes for injection pain.<xref rid="ref7" ref-type="bibr">7</xref> Medium-/long-chain propofol (M/LCT) can increase the lipid solubility and decrease the aqueous phase concentration of propofol by using medium-/long-chain fatty acids as solvents, thereby reducing the incidence rate of injection pain. The preparations of 10% medium-/long-chain triglycerides can decrease the aqueous phase concentration of propofol to (14.0 &#x000b1; 0.5) mg/L, with its injection pain reduced by 25% compared with that of long-chain triglyceride only [(18.6 &#x000b1; 0.6) mg/L]<xref rid="ref8" ref-type="bibr">8</xref> in the absence of other preventive measures. The incidence rate and degree of pain of the latter strategy remained almost unchanged even when 10 mg lidocaine was pre-injected. Compared with long-chain propofol, the injection pain of M/LCT can be markedly reduced,<xref rid="ref9" ref-type="bibr">9</xref> but the sample size is small. Besides, related studies on pediatric injection pain remain scarce.</p><p>Thereby motivated, we designed a randomized double-blinded prospective study to observe the incidence rate and degree of injection pain of M/LCT during induction of pediatric anesthesia using the VRS 4-point scale. The results were compared with those of injection of long-chain propofol, pre-injection of 0.5 mg/kg lidocaine or 0.2 mg/kg ketamine before propofol injection, and injection of 180 mg propofol mixed with 40 mg lidocaine or 16 mg ketamine. We aimed to provide evidence for the clinical application of M/LCT by evaluating the preventive effects of these regimens on the injection pain and adverse reactions of propofol.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><sec id="sec2-1"><title>Inclusion criteria</title><p>With approval by the ethics committee of our hospital and written consent of guardians; with preoperative scores classified by the American Society of Anesthesiologists (ASA) standards<xref rid="ref10" ref-type="bibr">10</xref> as Grade I to II; aged 5-12 years old.</p></sec><sec id="sec2-2"><title>Exclusion criteria</title><p>With body mass index &#x0003e;30 or &#x0003c;18; children allergic to local anesthetics, lipid drugs, propofol or ketamine; with asthma, neurological dysfunction or mental disorder; with preoperative ASA classification of Grade III-IV and emergency admission; with liver or kidney dysfunction; with phlebitis; with failure in venipuncture over twice; non-compliant children who cried and screamed.</p></sec><sec id="sec2-3"><title>Grouping</title><p>The eligible 360 patients who received elective surgery under general anesthesia were randomly divided into six groups (n=60) as follows. S group: The patients were given 2 ml of 0.9% sodium chloride (Sinopharm Group Co., Ltd., Beijing, China) and then a mixture of propofol (Beijing North Institute of Biological Technology, China) and 0.9% sodium chloride 30 s later; L group: the patients were given 0.5 mg/kg lidocaine (Beijing North Institute of Biological Technology, China) and then a mixture of propofol and 0.9% sodium chloride 30 s later; L + P group: the patients were given 2 ml of 0.9% sodium chloride and then a mixture of propofol and lidocaine 30 s later; K group: the patients were given 0.2 mg/kg ketamine (Beijing North Institute of Biological Technology, China) and then a mixture of propofol and 0.9% sodium chloride 30s later; K + P group: the patients were given 2 ml of 0.9% sodium chloride and then a mixture of propofol and ketamine 30 s later; M group: the patients were given 2 ml of 0.9% sodium chloride and then a mixture of propofol M/LCT (Beijing North Institute of Biological Technology, China) and 0.9% sodium chloride 30 s later.</p></sec><sec id="sec2-4"><title>Anesthetic methods</title><p>All patients underwent routine preoperative fasting, without any premedication. A 24G intravenous catheter was placed and connected with a t-tube that was thereafter rinsed with lactated Ringer&#x02019;s solution (Beijing SanYao Science &#x00026; Technology Development Co., Ltd., China). After the children stopped crying and screaming, they were randomly divided when the liquid infusion was unobstructed. Electrocardiogram, noninvasive blood pressure, saturation of pulse oximetry and end-tidal carbon dioxide partial pressure were routinely monitored (ABI PE-Applied Biosystem, Foster, CA, USA). A 2 ml syringe with 2 ml of drug was connected onto one end of the t-tube which was opened after the children became calm. Then the drug was injected at a speed of 1 ml/6 s. After the drug entered the cubital vein, the infusion channel was closed. Thirty seconds later, anesthesia induction was conducted by intravenous injection of 2.5 mg/kg propofol at a speed of 1 ml/6 s using a constant-speed pump. After consciousness disappeared or breathing stopped, the children were subjected to 100% oxygen-assisted ventilation, followed by injection of 2 &#x003bc;g/kg fentanyl (Novartis Pharma Schweiz AG, Oslo, Switzerland) and 0.2 mg/kg cis-atracurium besylate (Novartis Pharma Schweiz AG, Oslo, Switzerland) successively. After tracheal intubation was completed, the patients were subjected to inhalation anesthesia and inserted by laryngeal mask, and spontaneous breathing was maintained during surgery.</p></sec><sec id="sec2-5"><title>Observation indices</title><p>Throughout propofol infusion, the facial expressions, language responses, limb movements, arm retraction and crying of the patients were closely observed by an assistant, and their injection pain was scored with the VRS 4-point scale.<xref rid="ref11" ref-type="bibr">11</xref></p><p>With the most severe pain scored as 4 points, 0 point represents no pain, and 1-3 points all suggest pain occurs. The degrees of injection pain were classified as mild, moderate and severe, and the incidence rate of pain in each group was calculated. The heart rates before and during injection as well as the side effects of propofol, such as mental disorder, nausea and vomiting, diplopia, cardiac disorder and allergy, were recorded. After surgery, the patients were followed up for the pain and skin conditions of the venipuncture site to observe whether there were symptoms of phlebitis (e.g. redness and swelling).</p></sec><sec id="sec2-6"><title>Statistical analysis</title><p>All data were analyzed by SPSS16.0. The categorical data were expressed as mean &#x000b1; standard deviation. Inter-group comparisons were performed by one-way analysis of variance, and intra-group comparisons were conducted by repeated measures analysis of variance data. The numerical data were subjected to Chi-square test, and the ordinal data were subjected to rank sum test. The incidence rates of pain were compared by Chi-square test, and degrees of pain were compared by rank sum test. P&#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><sec id="sec2-7"><title>Baseline clinical data</title><p>The genders, ages, body weights, heights and ASA grades of all children were similar (P&#x0003e;0.05) (<xref ref-type="table" rid="T1">Table-I</xref>).</p><table-wrap id="T1" position="float"><label>Table-I</label><caption><p>Baseline clinical data (n=60).</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"><italic>Item</italic></th><th align="center" rowspan="1" colspan="1"><italic>Age (year)</italic></th><th align="center" rowspan="1" colspan="1"><italic>Body weight (kg)</italic></th><th align="center" rowspan="1" colspan="1"><italic>Height (cm)</italic></th><th align="center" rowspan="1" colspan="1"><italic>ASA grade (I/II)</italic></th><th align="center" rowspan="1" colspan="1"><italic>Gender (male/female)</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">S group</td><td align="center" rowspan="1" colspan="1">6.43&#x000b1;1.68</td><td align="center" rowspan="1" colspan="1">21.38&#x000b1;4.17</td><td align="center" rowspan="1" colspan="1">113.55&#x000b1;8.97</td><td align="center" rowspan="1" colspan="1">40/20</td><td align="center" rowspan="1" colspan="1">38/22</td></tr><tr><td align="left" rowspan="1" colspan="1">L group</td><td align="center" rowspan="1" colspan="1">6.36&#x000b1;1.77</td><td align="center" rowspan="1" colspan="1">23.36&#x000b1;5.77</td><td align="center" rowspan="1" colspan="1">111.77&#x000b1;9.78</td><td align="center" rowspan="1" colspan="1">41/19</td><td align="center" rowspan="1" colspan="1">39/21</td></tr><tr><td align="left" rowspan="1" colspan="1">L + P group</td><td align="center" rowspan="1" colspan="1">6.72&#x000b1;1.35</td><td align="center" rowspan="1" colspan="1">21.68&#x000b1;6.63</td><td align="center" rowspan="1" colspan="1">103.98&#x000b1;7.19</td><td align="center" rowspan="1" colspan="1">44/16</td><td align="center" rowspan="1" colspan="1">36/24</td></tr><tr><td align="left" rowspan="1" colspan="1">K group</td><td align="center" rowspan="1" colspan="1">6.68&#x000b1;1.57</td><td align="center" rowspan="1" colspan="1">21.36&#x000b1;7.39</td><td align="center" rowspan="1" colspan="1">110.36&#x000b1;9.73</td><td align="center" rowspan="1" colspan="1">34/6</td><td align="center" rowspan="1" colspan="1">40/20</td></tr><tr><td align="left" rowspan="1" colspan="1">K + P group</td><td align="center" rowspan="1" colspan="1">7.13&#x000b1;1.68</td><td align="center" rowspan="1" colspan="1">23.55&#x000b1;6.31</td><td align="center" rowspan="1" colspan="1">113.58&#x000b1;8.99</td><td align="center" rowspan="1" colspan="1">33/7</td><td align="center" rowspan="1" colspan="1">38/22</td></tr><tr><td align="left" rowspan="1" colspan="1">M group</td><td align="center" rowspan="1" colspan="1">7.15&#x000b1;1.98</td><td align="center" rowspan="1" colspan="1">24.17&#x000b1;4.99</td><td align="center" rowspan="1" colspan="1">113.77&#x000b1;10.93</td><td align="center" rowspan="1" colspan="1">33/7</td><td align="center" rowspan="1" colspan="1">36/24</td></tr><tr><td align="left" rowspan="1" colspan="1">F value</td><td align="center" rowspan="1" colspan="1">1.351</td><td align="center" rowspan="1" colspan="1">0.779</td><td align="center" rowspan="1" colspan="1">0.636</td><td align="center" rowspan="1" colspan="1">1.13</td><td align="center" rowspan="1" colspan="1">2.797</td></tr><tr><td align="left" rowspan="1" colspan="1">P value</td><td align="center" rowspan="1" colspan="1">0.298</td><td align="center" rowspan="1" colspan="1">0.398</td><td align="center" rowspan="1" colspan="1">0.798</td><td align="center" rowspan="1" colspan="1">10.993</td><td align="center" rowspan="1" colspan="1">0.756</td></tr></tbody></table></table-wrap></sec><sec id="sec2-8"><title>Incidence rates of propofol injection pain</title><p>The incidence rates of injection pain of S group, L group, L + P group, K group, K + P group and M group were 78.3%, 66.67%, 51.66%, 43.33%, 48.33% and 45% respectively. The incidence rates of all experimental groups were significantly lower than that of S group (P&#x0003c;0.01). Besides, the incidence rates of L + P group, K group, K + P group and M group were significantly lower than that of L group (P&#x0003c;0.05). The differences among the other groups were not statistically significant (P&#x0003e;0.05).</p></sec><sec id="sec2-9"><title>Degrees of propofol injection pain</title><p>The degrees of propofol injection pain were evaluated by the VRS 4-point scale (<xref ref-type="table" rid="T2">Table-II</xref>), and inter-group comparisons were conducted with rank sum test. All the experimental groups had significantly lower degrees of injection pain than that of the control group, and there were significant inter-group differences (P&#x0003c;0.01).</p><table-wrap id="T2" position="float"><label>Table-II</label><caption><p>Degrees of injection pain (case, n=60).</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"><italic>Group</italic></th><th align="center" rowspan="1" colspan="1"><italic>Painless</italic></th><th align="center" rowspan="1" colspan="1"><italic>Mild pain</italic></th><th align="center" rowspan="1" colspan="1"><italic>Moderate pain</italic></th><th align="center" rowspan="1" colspan="1"><italic>Severe pain</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">S group</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">L group</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">L + P group</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">K group</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">K + P group</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">M group</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">1</td></tr></tbody></table></table-wrap></sec><sec id="sec2-10"><title>Heart rates before and after injection</title><p>The heart rates of all groups, which were similar before propofol injection (P&#x0003e;0.05), were significantly elevated after it (P&#x0003c;0.05). After injection, S group had significantly higher heart rate than those of L + P, K + P and M groups (P&#x0003c;0.05). The heart rate of L group was significantly higher than those of L + P and K + P groups (P&#x0003c;0.05). The heart rates of other groups were not significantly different (P&#x0003e;0.05) (<xref ref-type="table" rid="T3">Table-III</xref>).</p><table-wrap id="T3" position="float"><label>Table-III</label><caption><p>Heart rates before and after injection.</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"><italic>Item</italic></th><th align="center" rowspan="1" colspan="1"><italic>Before injection</italic></th><th align="center" rowspan="1" colspan="1"><italic>After injection</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">S group</td><td align="center" rowspan="1" colspan="1">92.63&#x000b1;10.33</td><td align="center" rowspan="1" colspan="1">116.43&#x000b1;12.46<xref ref-type="table-fn" rid="t3f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">L group</td><td align="center" rowspan="1" colspan="1">94.78&#x000b1;12.33</td><td align="center" rowspan="1" colspan="1">116.47&#x000b1;12.49<xref ref-type="table-fn" rid="t3f1">*</xref><xref ref-type="table-fn" rid="t3f2">#</xref><xref ref-type="table-fn" rid="t3f3">&#x00394;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">L + P group</td><td align="center" rowspan="1" colspan="1">95.77&#x000b1;10.56</td><td align="center" rowspan="1" colspan="1">105.35&#x000b1;9.47<xref ref-type="table-fn" rid="t3f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">K group</td><td align="center" rowspan="1" colspan="1">97.35&#x000b1;11.28</td><td align="center" rowspan="1" colspan="1">109.38&#x000b1;12.76<xref ref-type="table-fn" rid="t3f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">K + P group</td><td align="center" rowspan="1" colspan="1">93.56&#x000b1;13.46</td><td align="center" rowspan="1" colspan="1">105.33&#x000b1;13.47<xref ref-type="table-fn" rid="t3f1">*</xref><xref ref-type="table-fn" rid="t3f2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">M group</td><td align="center" rowspan="1" colspan="1">94.99&#x000b1;10.37</td><td align="center" rowspan="1" colspan="1">106.48&#x000b1;10.47<xref ref-type="table-fn" rid="t3f1">*</xref><xref ref-type="table-fn" rid="t3f2">#</xref><xref ref-type="table-fn" rid="t3f3">&#x00394;</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Compared with heart rate before injection,</p></fn><fn id="t3f1"><label>*</label><p>P&#x0003c;0.05; compared with S group,</p></fn><fn id="t3f2"><label>#</label><p>P&#x0003c;0.05; compared with L group,</p></fn><fn id="t3f3"><label>&#x00394;</label><p>P&#x0003c;0.05.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-11"><title>Adverse reactions after injection</title><p>After propofol injection, there were no significant differences between the adverse reactions of all groups (P&#x0003e;0.05) (<xref ref-type="table" rid="T4">Table-IV</xref>).</p><table-wrap id="T4" position="float"><label>Table-IV</label><caption><p>Adverse reactions after injection (n=60).</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"><italic>Group</italic></th><th align="center" rowspan="1" colspan="1"><italic>Mental disorder</italic></th><th align="center" rowspan="1" colspan="1"><italic>Nausea and vomiting</italic></th><th align="center" rowspan="1" colspan="1"><italic>Diplopia</italic></th><th align="center" rowspan="1" colspan="1"><italic>Cardiac disorder</italic></th><th align="center" rowspan="1" colspan="1"><italic>Allergy</italic></th><th align="center" rowspan="1" colspan="1"><italic>Phlebitis</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">S group</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">L group</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">L + P group</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">K group</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">K + P group</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">M group</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>As an innovation of anesthesia, propofol has now been widely used due to rapid action and short functioning time. However, it mainly suffers from injection pain,<xref rid="ref12" ref-type="bibr">12</xref> as an inevitable issue of which even adults are afraid.<xref rid="ref13" ref-type="bibr">13</xref> With elusive mechanisms, the injection pain of propofol has mainly been attributed to the pain-inducing effect originating from the contact between aqueous phase of emulsion and free nerve endings<xref rid="ref14" ref-type="bibr">14</xref> or the delaying effect based on bradykinin produced by the activated kinin cascade system.<xref rid="ref15" ref-type="bibr">15</xref> Bradykinin leads to local phlebectasia and increases vascular wall permeability, so propofol can penetrate the vascular wall to contact with more free nerve endings, thus aggravating the injection pain.<xref rid="ref16" ref-type="bibr">16</xref></p><p>The incidence rates of propofol injection pain in adults range from 28% to 90%, while those of children range between 30% and 90%. Mixing propofol with 1% lidocaine in inducing the anesthesia of preschoolers can dramatically reduce the injection pain (59% vs 22.5%).<xref rid="ref17" ref-type="bibr">17</xref> Lidocaine may be able to stabilize the kinin cascade induced by propofol. Nevertheless, lidocaine usually destabilizes propofol injection to produce lipid droplets, and those larger than 5 &#x003bc;m may result in fat embolism.<xref rid="ref18" ref-type="bibr">18</xref></p><p>In this study, S and L groups were more prone to propofol injection pain than other groups, probably because the patients did not receive premedication and fine puncture needles were used for veins. M/LCT, as a novel preparation that dissolves propofol in 10% medium-/long-chain triglyceride, can mitigate the injection pain by decreasing the free concentration of propofol in aqueous phase. It works for both adults and children.</p><p>The incidence rate of pain after M/LCT injection, which was significantly lower than that after normal saline treatment (47.5% vs 95%), was slightly higher (0.2%) than that after pre-mixing lidocaine (P&#x0003e;0.05). As the receptor antagonist for N-methyl-D-aspartate, ketamine allows local anesthesia<xref rid="ref19" ref-type="bibr">19</xref> and exerts an analgesic effect at low dose.<xref rid="ref20" ref-type="bibr">20</xref> Pre-injection of 10 mg ketamine can reduce the incidence rate of injection pain from 84% to 26% and also partially counteract the blood pressure-reducing effect of propofol.<xref rid="ref21" ref-type="bibr">21</xref></p><p>The injection pain of propofol is manifested as immediate pain or delayed pain (delayed by 10-20s).<xref rid="ref22" ref-type="bibr">22</xref> To prevent the immediate pain, ketamine was injected 30s before propofol injection. Pre-injecting or mixing low-dose ketamine both decreased the incidence rate of injection pain, exceeding the outcomes using 0.2 mg/kg lidocaine pre-injection. Meanwhile, the hemodynamics was not obviously affected. Nevertheless, ketamine has well-documented side effects such as delayed recovery, postoperative nausea and vomiting, and mental excitement.<xref rid="ref23" ref-type="bibr">23</xref> In our study, the adverse reactions of all groups were not significantly different, which may be ascribed to the low dose of ketamine and the small sample size.</p><p>Given that pain is affected by various subjective factors, it is crucial to stabilize the psychological states of patients by establishing a quiet, peaceful environment, communicating with them, allowing family companion and toy playing, and relieving their anxiety to the maximum extent.<xref rid="ref24" ref-type="bibr">24</xref> Though we had endeavored to eliminate the above factors, subjective backgrounds such as mental health, degree of awareness and pain tolerance could not be determined based on fixed criteria, so the experimental results may be affected.</p><p>To relieve the injection pain of propofol, researchers have been devoted to the following two aspects. First is the combination of several drugs.<xref rid="ref25" ref-type="bibr">25</xref> For instance, Zhang et al. evaluated the pain on injection of propofol via different combinations of fentanyl, sufentanil or remifentanil in gastrointestinal endoscopy.<xref rid="ref26" ref-type="bibr">26</xref> They found that propofol and sufentanil group was the most suitable program for painless gastroscopy. Second is the use of M/LCT as the solvent. West et al. compared and systematically assessed the effects of several anesthesia methods, and reported that using M/LCT effectively mitigated the injection pain of propofol.<xref rid="ref9" ref-type="bibr">9</xref> In this study, we tested the effects of both drug combination and M/LCT.</p><p>In summary, the injection pain of propofol was significantly alleviated by using M/LCT, pre-injecting 0.5 mg/kg lidocaine or 0.2 mg/kg ketamine, or pre-mixing 180 mg propofol with 40 mg lidocaine or 16 mg ketamine, with significant differences from those of the control group treated by normal saline (P&#x0003c;0.01). Hence, they are potentially effective strategies for preventing the injection pain of propofol. However, the dose and combination of these anesthetics should be further studied to eliminate such pain.</p><sec id="sec2-12"><title>Authors&#x02019; contributions</title><p><bold>DC &#x00026; LL:</bold> Data collection and analysis.</p><p><bold>ZH:</bold> Study design and manuscript writing.</p></sec></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold><italic>Declaration of interest:</italic></bold> All authors have no conflict of interest regarding thispaper.</p></fn><fn fn-type="supported-by"><p><bold><italic>Source of funding:</italic></bold> None.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chidambaran</surname><given-names>V</given-names></name><name><surname>Costandi</surname><given-names>A</given-names></name><name><surname>D&#x02019;Mello</surname><given-names>A</given-names></name></person-group><article-title>Propofol: a review of its role in pediatric anesthesia and sedation</article-title><source>CNS Drugs</source><year>2015</year><volume>29</volume><fpage>543</fpage><lpage>563</lpage><comment>doi:10.1007/s40263-015-0259-6</comment><pub-id pub-id-type="pmid">26290263</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habre</surname><given-names>C</given-names></name><name><surname>Tram&#x000e8;r</surname><given-names>MR</given-names></name><name><surname>P&#x000f6;pping</surname><given-names>DM</given-names></name><name><surname>Elia</surname><given-names>N</given-names></name></person-group><article-title>Ability of a meta-analysis to prevent redundant research: systematic review of studies on pain from propofol injection</article-title><source>BMJ</source><year>2014</year><volume>348</volume><fpage>g5219</fpage><comment>doi:10.1136/bmj.g5219</comment><pub-id pub-id-type="pmid">25161280</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goktug</surname><given-names>A</given-names></name><name><surname>Gulec</surname><given-names>H</given-names></name><name><surname>Takmaz</surname><given-names>SA</given-names></name><name><surname>Turkyilmaz</surname><given-names>E</given-names></name><name><surname>Basar</surname><given-names>H</given-names></name></person-group><article-title>Lidocaine alleviates propofol related pain much better than metoprolol and nitroglycerin</article-title><source>Braz J Anesthesiol</source><year>2015</year><volume>65</volume><fpage>338</fpage><lpage>342</lpage><comment>doi:10.1016/j.bjane.2014.01.006</comment><pub-id pub-id-type="pmid">26323730</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther-Larsen</surname><given-names>S</given-names></name><name><surname>Aagaard</surname><given-names>GB</given-names></name><name><surname>Friis</surname><given-names>SM</given-names></name><name><surname>Petersen</surname><given-names>T</given-names></name><name><surname>M&#x000f8;ller-Sonnergaard</surname><given-names>J</given-names></name><name><surname>R&#x000f8;msing</surname><given-names>J</given-names></name></person-group><article-title>Structured intervention for management of pain following day surgery in children</article-title><source>Paediatr Anaesth</source><year>2016</year><volume>26</volume><fpage>151</fpage><lpage>157</lpage><comment>doi:10.1111/pan.12811</comment><pub-id pub-id-type="pmid">26559643</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name></person-group><article-title>Propofol versus Midazolam for Sedation during Esophagogastroduodenoscopy in Children</article-title><source>Clin Endosc</source><year>2013</year><volume>46</volume><fpage>368</fpage><lpage>372</lpage><comment>doi:10.5946/ce.2013.46.4.368</comment><pub-id pub-id-type="pmid">23964333</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name></person-group><article-title>Efficacy of ondansetron for the prevention of propofol injection pain: a meta-analysis</article-title><source>J Pain Res</source><year>2017</year><volume>10</volume><fpage>445</fpage><lpage>450</lpage><comment>doi:10.2147/JPR.S128992</comment><pub-id pub-id-type="pmid">28260943</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damitz</surname><given-names>R</given-names></name><name><surname>Chauhan</surname><given-names>A</given-names></name></person-group><article-title>Rapid dissolution of propofol emulsions under sink conditions</article-title><source>Int J Pharm</source><year>2015</year><volume>481</volume><fpage>47</fpage><lpage>55</lpage><comment>doi:10.1016/j.ijpharm.2015.01.045</comment><pub-id pub-id-type="pmid">25636303</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>AY</given-names></name><name><surname>Kaye</surname><given-names>AD</given-names></name><name><surname>Kaye</surname><given-names>RJ</given-names></name><name><surname>Belani</surname><given-names>K</given-names></name><name><surname>Urman</surname><given-names>RD</given-names></name></person-group><article-title>Novel propofol derivatives and implications for anesthesia practice</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2017</year><volume>33</volume><fpage>9</fpage><lpage>15</lpage><comment>doi:10.4103/0970-9185.202205</comment><pub-id pub-id-type="pmid">28413268</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>N</given-names></name><name><surname>Dumont</surname><given-names>GA</given-names></name><name><surname>van Heusden</surname><given-names>K</given-names></name><name><surname>Petersen</surname><given-names>CL</given-names></name><name><surname>Khosravi</surname><given-names>S</given-names></name><name><surname>Soltesz</surname><given-names>K</given-names></name><etal/></person-group><article-title>Robust closed-loop control of induction and maintenance of propofol anesthesia in children</article-title><source>Paediatr Anaesth</source><year>2013</year><volume>23</volume><fpage>712</fpage><lpage>719</lpage><comment>doi:10.1111/pan.12183</comment><pub-id pub-id-type="pmid">23668370</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouse</surname><given-names>CJ</given-names></name><name><surname>Karlen</surname><given-names>W</given-names></name><name><surname>Dumont</surname><given-names>GA</given-names></name><name><surname>Myers</surname><given-names>D</given-names></name><name><surname>Cooke</surname><given-names>E</given-names></name><name><surname>Stinson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Monitoring nociception during general anesthesia with cardiorespiratory coherence</article-title><source>J Clin Monit Comput</source><year>2013</year><volume>27</volume><fpage>551</fpage><lpage>560</lpage><comment>doi:10.1007/s10877-013-9463-4</comment><pub-id pub-id-type="pmid">23568315</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Koo</surname><given-names>BN</given-names></name></person-group><article-title>Comparison of emergence time in children undergoing minor surgery according to anesthetic: desflurane and sevoflurane</article-title><source>Yonsei Med J</source><year>2013</year><volume>54</volume><fpage>732</fpage><lpage>738</lpage><comment>doi:10.3349/ymj.2013.54.3.732</comment><pub-id pub-id-type="pmid">23549823</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>HS</given-names></name><name><surname>Singh</surname><given-names>LD</given-names></name><name><surname>Singh</surname><given-names>NR</given-names></name><name><surname>Singh</surname><given-names>TH</given-names></name><name><surname>Thokchom</surname><given-names>RS</given-names></name><name><surname>Monohar</surname><given-names>PS</given-names></name></person-group><article-title>Effects of dexmedetomidine and lidocaine in alleviating propofol injection pain: A randomized controlled trial</article-title><source>J Med Soc</source><year>2015</year><volume>29</volume><fpage>31</fpage><lpage>34</lpage><comment>doi:10.4103/0972-4958.158929</comment></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Euasobhon</surname><given-names>P</given-names></name><name><surname>Dej-Arkom</surname><given-names>S</given-names></name><name><surname>Siriussawakul</surname><given-names>A</given-names></name><name><surname>Muangman</surname><given-names>S</given-names></name><name><surname>Sriraj</surname><given-names>W</given-names></name><name><surname>Pattanittum</surname><given-names>P</given-names></name><etal/></person-group><article-title>Lidocaine for reducing propofol-induced pain on induction of anaesthesia in adults</article-title><source>Cochrane Database Syst Rev</source><year>2016</year><volume>2</volume><fpage>CD007874</fpage><comment>doi:10.1002/14651858.CD007874.pub2</comment><pub-id pub-id-type="pmid">26888026</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Kwon</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Jeon</surname><given-names>Y</given-names></name></person-group><article-title>Comparative evaluation of the effect of remifentanil and 2 different doses of esmolol on pain during propofol injection: A double-blind, randomized clinical consort study</article-title><source>Medicine (Baltimore)</source><year>2017</year><volume>96</volume><fpage>e6288</fpage><comment>doi:10.1097/MD.0000000000006288</comment><pub-id pub-id-type="pmid">28272252</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimoto</surname><given-names>R</given-names></name><name><surname>Kashio</surname><given-names>M</given-names></name><name><surname>Tominaga</surname><given-names>M</given-names></name></person-group><article-title>Propofol-induced pain sensation involves multiple mechanisms in sensory neurons</article-title><source>Pflugers Arch</source><year>2015</year><volume>467</volume><fpage>2011</fpage><lpage>2020</lpage><comment>doi:10.1007/s00424-014-1620-1</comment><pub-id pub-id-type="pmid">25301522</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e53311</fpage><comment>doi:10.1371/journal.pone.0053311</comment><pub-id pub-id-type="pmid">23308191</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>DP</given-names></name><name><surname>Bhalla</surname><given-names>T</given-names></name><name><surname>Thung</surname><given-names>A</given-names></name><name><surname>Rice</surname><given-names>J</given-names></name><name><surname>Beebe</surname><given-names>A</given-names></name><name><surname>Samora</surname><given-names>W</given-names></name><etal/></person-group><article-title>A preliminary study of volatile agents or total intravenous anesthesia for neurophysiological monitoring during posterior spinal fusion in adolescents with idiopathic scoliosis</article-title><source>Spine (Phila Pa 1976)</source><year>2014</year><volume>39</volume><fpage>E1318</fpage><lpage>1324</lpage><comment>doi:10.1097/BRS.0000000000000550</comment><pub-id pub-id-type="pmid">25099322</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costi</surname><given-names>D</given-names></name><name><surname>Cyna</surname><given-names>AM</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Stephens</surname><given-names>K</given-names></name><name><surname>Strickland</surname><given-names>P</given-names></name><name><surname>Ellwood</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effects of sevoflurane versus other general anaesthesia on emergence agitation in children</article-title><source>Cochrane Database Syst Rev</source><year>2014</year><fpage>CD007084</fpage><comment>doi:10.1002/14651858.CD007084.pub2</comment><pub-id pub-id-type="pmid">25212274</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Kang</surname><given-names>YR</given-names></name><name><surname>Koo</surname><given-names>BN</given-names></name></person-group><article-title>Low-dose dexmedetomidine reduces emergence agitation after desflurane anaesthesia in children undergoing strabismus surgery</article-title><source>Yonsei Med J</source><year>2014</year><volume>55</volume><fpage>508</fpage><lpage>516</lpage><comment>doi:10.3349/ymj.2014.55.2.508</comment><pub-id pub-id-type="pmid">24532525</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiaretti</surname><given-names>A</given-names></name><name><surname>Benini</surname><given-names>F</given-names></name><name><surname>Pierri</surname><given-names>F</given-names></name><name><surname>Vecchiato</surname><given-names>K</given-names></name><name><surname>Ronfani</surname><given-names>L</given-names></name><name><surname>Agosto</surname><given-names>C</given-names></name><etal/></person-group><article-title>Safety and efficacy of propofol administered by paediatricians during procedural sedation in children</article-title><source>Acta Paediatr</source><year>2014</year><volume>103</volume><fpage>182</fpage><lpage>187</lpage><comment>doi:10.1111/apa.12472</comment><pub-id pub-id-type="pmid">24138461</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallah</surname><given-names>R</given-names></name><name><surname>Ferdosian</surname><given-names>F</given-names></name><name><surname>Shajari</surname><given-names>A</given-names></name></person-group><article-title>Non-Parenteral Medications for Procedural Sedation in Children- A Narrative: Review Article</article-title><source>Iran J Child Neurol</source><year>2015</year><volume>9</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandar</surname><given-names>R</given-names></name><name><surname>Jagadisan</surname><given-names>B</given-names></name><name><surname>Vasudevan</surname><given-names>A</given-names></name></person-group><article-title>Propofol-ketamine and propofol-fentanyl combinations for nonanesthetist-administered sedation</article-title><source>J Pediatr Gastroenterol Nutr</source><year>2015</year><volume>60</volume><fpage>762</fpage><lpage>768</lpage><comment>doi:10.1097/MPG.0000000000000722</comment><pub-id pub-id-type="pmid">25996793</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><name><surname>Wei</surname><given-names>HY</given-names></name><name><surname>Lao</surname><given-names>JQ</given-names></name><name><surname>Wang</surname><given-names>HP</given-names></name><name><surname>Tian</surname><given-names>YY</given-names></name></person-group><article-title>Rapid sedation induced by fentanyl combined with propofol via an intrathecal chemotherapy injection for leukemia in children</article-title><source>Genet Mol Res</source><year>2015</year><volume>14</volume><fpage>3687</fpage><lpage>3693</lpage><comment>doi:10.4238/2015.April.17.18</comment><pub-id pub-id-type="pmid">25966137</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>D</given-names></name></person-group><article-title>Effect of dexmedetomidine on preventing postoperative agitation in children: a meta-analysis</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e128450</fpage><comment>doi:10.1371/journal.pone.0128450</comment></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronson</surname><given-names>JK</given-names></name></person-group><article-title>Management of pain during injection of propofol</article-title><source>Adverse Drug React Bull</source><year>2014</year><volume>287</volume><fpage>1107</fpage><lpage>1110</lpage><comment>doi:10.1097/FAD.0000000000000005</comment></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name></person-group><article-title>Comparing the pain of propofol via different combinations of fentanyl, sufentanil or remifentanil in gastrointestinal endoscopy</article-title><source>Acta Cir Bras</source><year>2014</year><volume>29</volume><fpage>675</fpage><lpage>680</lpage><comment>doi:10.1590/S0102-8650201400160008</comment><pub-id pub-id-type="pmid">25318000</pub-id></element-citation></ref></ref-list></back></article>